BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 835932)

  • 1. Systemic therapy for metastatic breast cancer.
    Haskell CM; Sparks FC; Graze PR; Korenman SG
    Ann Intern Med; 1977 Jan; 86(1):68-80. PubMed ID: 835932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiestrogen, cytotoxic chemotherapy, and bacillus Calmette-Guerin vaccination in stage II breast cancer: a preliminary report.
    Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
    Surgery; 1980 May; 87(5):494-501. PubMed ID: 7368100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic treatment of breast cancer: past, present and future.
    Carbone PP
    Int J Radiat Oncol Biol Phys; 1976; 1(7-8):759-67. PubMed ID: 977407
    [No Abstract]   [Full Text] [Related]  

  • 4. Management of metastatic breast cancer.
    Haskell CM
    Med Clin North Am; 1977 Sep; 61(5):967-78. PubMed ID: 330978
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant endocrine therapy, cytotoxic chemotherapy and immunotherapy in stage II breast cancer: 6-year result.
    Hubay CA; Pearson OH; Manni A; Gordon NH; McGuire WL
    J Steroid Biochem; 1985 Dec; 23(6B):1147-50. PubMed ID: 3912620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiestrogen-cytotoxic chemotherapy and bacillus Calmette-Guerin vaccination in stage II breast cancer: seventy-two-month follow-up.
    Hubay CA; Gordon NH; Crowe JP; Guyton SP; Pearson OH; Marshall JS; Mansour EG; Hermann RE; Jones JC; Flynn WJ
    Surgery; 1984 Jul; 96(1):61-72. PubMed ID: 6740497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant chemotherapy, anti-estrogen therapy and immunotherapy for stage II breast cancer.
    Hubay CA; Pearson OH; Marshall JS; Rhodes RS; Debanne SM; Mansour EG; Hermann RE; Jones JC; Flynn WJ; Eckert C; McGuire WL
    Eur J Cancer (1965); 1980; Suppl 1():189-95. PubMed ID: 7032932
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of nonspecific immunotherapy in the treatment of breast cancer.
    Israel L
    Recent Results Cancer Res; 1976; (57):189-95. PubMed ID: 1013508
    [No Abstract]   [Full Text] [Related]  

  • 9. Adjuvant systemic therapy for women with node-positive breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S52-64. PubMed ID: 9484279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adriamycin-combination chemotherapy with or without immune stimulation by corynebacterium parvum in metastasizing carcinoma of the breast (author's transl)].
    Mayr AC; Senn HJ; Gallmeier WM; Bruntsch U; Becher R; Drings P; Fritze D; Kaufmann M; Queisser W; Kempgens U
    Dtsch Med Wochenschr; 1979 Dec; 104(49):1739-43. PubMed ID: 510206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.
    Jonat W; Kaufmann M; Sauerbrei W; Blamey R; Cuzick J; Namer M; Fogelman I; de Haes JC; de Matteis A; Stewart A; Eiermann W; Szakolczai I; Palmer M; Schumacher M; Geberth M; Lisboa B;
    J Clin Oncol; 2002 Dec; 20(24):4628-35. PubMed ID: 12488406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of breast cancer.
    Cohen IA; Keller JH; Abate MA
    Clin Pharm; 1982; 1(6):515-29. PubMed ID: 6192963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response of disseminated breast cancer to combined modality treatment with chemotherapy and levamisole with or without Bacillus Calmette-GuĂ©rin.
    Hortobagyi GN; Yap HY; Blumenschein GR; Gutterman JU; Buzdar AU; Tashima CK; Hersh EM
    Cancer Treat Rep; 1978 Nov; 62(11):1685-92. PubMed ID: 728894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year update.
    Glick JH; Fowble BL; Haller DG; Rosato EF; Mackie JA; Weiler C; Glover DJ; Fox KR; Hurwitz S; Goodman RL
    NCI Monogr; 1988; (6):297-301. PubMed ID: 3352774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemo-immuno-therapy with LMF+BCG in node-negeative and node-positive breast cancer.
    Senn HJ; Jungi WF; Amgwerd R; Sprenger F; Hochuli E; Engelhart G; Heinz C; Wick A; Enderlin F; Simeon B; Lanz R; Bigler R
    Haematol Blood Transfus; 1978; 22():47-60. PubMed ID: 374199
    [No Abstract]   [Full Text] [Related]  

  • 16. Sequential methotrexate and fluorouracil for the treatment of node-negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from National Surgical Adjuvant Breast and Bowel Project (NSABP) B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil.
    Fisher B; Dignam J; Mamounas EP; Costantino JP; Wickerham DL; Redmond C; Wolmark N; Dimitrov NV; Bowman DM; Glass AG; Atkins JN; Abramson N; Sutherland CM; Aron BS; Margolese RG
    J Clin Oncol; 1996 Jul; 14(7):1982-92. PubMed ID: 8683228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of advanced breast cancer with cyclophosphamide, 5-fluorouracil, and prednisone with and without methanol-extracted residue of BCG.
    Britell JC; Ahmann DL; Bisel HF; Frytak S; Ingle JN; Rubin J; O'Fallon JR
    Cancer Clin Trials; 1979; 2(4):345-50. PubMed ID: 394870
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoimmunotherapy for metastatic breast cancer with 5-fluorouracil, adriamycin, cyclophosphamide, methotrexate, L-asparaginase, Corynebacterium parvum, and Pseudomonas vaccine.
    Hortobagyi GN; Yap HY; Wiseman CL; Blumenschein GR; Buzdar AU; Legha SS; Gutterman JU; Hersh EM; Bodey GP
    Cancer Treat Rep; 1980 Jan; 64(1):157-9. PubMed ID: 6991103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemo-immunotherapy for unresectable bronchogenic carcinoma.
    Sarna GP; Lowitz BB; Haskell CM; Dorey FJ; Cline MJ
    Cancer Treat Rep; 1978 May; 62(5):681-7. PubMed ID: 350397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of a castration-mediated effect of adjuvant cytotoxic chemotherapy in premenopausal breast cancer.
    Brincker H; Rose C; Rank F; Mouridsen HT; Jakobsen A; Dombernowsky P; Panduro J; Andersen KW
    J Clin Oncol; 1987 Nov; 5(11):1771-8. PubMed ID: 3316514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.